Abstract: Reduction of Acute Respiratory Illness (ARI) due to a Voluntary Workplace Influenza
Annual attack rates of influenza average from 10 to 20 percent, with the incidences of children and teenagers known to be the highest and mortality being greatest among the elderly population 1, 2) . Influenza is sometimes associated with malaise persistent for several weeks, which results in restriction of activity and accounts for millions of days lost from work each year [3] [4] [5] . Vaccines with a composition matching yearly World Health Organization recommendations are around 70% efficacious in the prevention of influenza caused by influenza viruses A and B. The effectiveness of influenza vaccination to prevent influenza-like illness or acute respiratory illness was reported to be around 35% 6, 7) . Vaccination with inactivated influenza vaccine is recommended for adults and children who are at increased risk for complications from influenza due to the following medical conditions: chronic disorders of the pulmonary or cardiovascular systems, chronic metabolic diseases, and immune suppression 8) . In 1998, Taiwan adopted influenza vaccination for the first time, providing it to the disabled and to people older than 65 yr of age. At the same time, a Taiwanese electronics manufacturing company was informed of the potential benefit of such a vaccination and decided to conduct an influenza vaccination program.
Acute respiratory illness (ARI) has become a tremendous public health challenge since the outbreak of SARS (Severe Acute Respiratory Syndrome) in 2003 and avian influenza in 2004 9, 10) . Because SARS and avian influenza showed influenza-like symptoms, a case of real influenza may cause a false alarm for a company to take serious isolation policy during epidemic of a new emerging infectious disease. To minimize possible confusion in differential diagnosis for SARS and avian influenza, the CDC (Center for Disease Control) of Taiwan recommended influenza vaccination to all the health care workers, poultry workers, and people of old age in 2003, but there are still debates on the costeffectiveness of providing influenza vaccination to healthy working populations and young adults without underlying risk factors 10) . In this study we attempted to determine the potential effectiveness of influenza vaccination in the working population, and its possible effectiveness in the reduction of sickness absence and clinic visits due to ARI. We also attempted to explore possible determinants that might identify specific subgroups with the most benefit from the vaccination. The vaccination program in the aforementioned electronics company provided us an opportunity for this study.
Subjects and Methods

Study Subjects and Design
This is a voluntary vaccination program. In late 1998, the occupational health clinic of a Taiwanese electronics manufacturing company began providing the influenza vaccine to its employees for the first time. All employees at the company were informed of the program and encouraged to receive the vaccination. The company paid half of the vaccination cost to promote employees' participation. Information on vaccination status, incidence of illness and sickness absence, as well as other medical conditions was obtained during the period January to April 1998 and 1999 respectively. In Taiwan, the period of influenza epidemics is usually during January to April. Thus, the study was conducted during that period.
Data Collection
Exposure Data: Eligibility for vaccination was screened by a physician with a predefined set of criteria, which included no history of immediate hypersensitive reaction to eggs and a normal body temperature without any acute symptoms or illnesses. All vaccine recipients were required to give their written informed consent. Corporate occupational health nurses provided the vaccine to the recipients between Oct. 27 and Nov. 7, 1998 . Each one of them received a 0.5 ml injection of a purified, splitvirus influenza vaccine (Vaxigrip 1998/1999 strain, France) given intramuscularly in the deltoid muscle.
Outcome Data: The primary outcome was the 4-month incidence rate of clinic visits due to ARI and total sickness absence during the follow up period of January-April in both 1998 and 1999. An ARI clinic visit was defined as any workers who visited the company health clinic due to a sore throat associated with either fever or a cough, or any acute respiratory symptom such as rhinorrhea accompanied with a sudden onset of headache, myalgia, fever and prostration. Because the cost of such a vaccination was not regularly reimbursed in the National Health Insurance, its record was kept in a separate file other than the medical record, so that the physician did not know whether the patient had been vaccinated or not. Individual medical records of dates and reasons for their clinic visits during the follow up periods were abstracted from the occupational health clinic. To conservatively estimate the 4-month incidence of ARI clinic visits, individual ARI clinic visits were counted only as one case if the worker visited the company health clinic more than once during the 4-month period. Data on sickness absence man-hours were collected from the company's personnel database.
Data on Potential Confounders:
Potential confounders of the effectiveness of influenza vaccine include each employee's demographic information, and health profile as well as health behavior. Basic demographic information on the employees was obtained from the company. Employee health profiles, including common health behavior and personal medical history, were obtained from the 1998 annual health examination that the company provided to all of its employees. Information in relation to health behavior includes smoking, drinking and exercise habits etc.
In the employee health profile analysis, we followed the diagnostic guidelines of the sixth Report of the Joint National Committee on Prevention, Detection, and Treatment of High Blood Pressure 11) . Systolic blood pressure over 140 mmHg, diastolic blood pressure over 90 mmHg, or workers who were under hypertensive treatment were considered hypertensive patients. The diagnosis of diabetes mellitus (DM), suggested by the Expert Committee on the classification of DM, was used, i.e. plasma glucose levels above 126 mg/dl were considered as diabetic 12, 13) . A BMI (body mass index) of more than 25 is classified as overweight 10) . A cholesterol level over 200 mg/dl is accepted as a risk factor for coronary artery disease 14, 15) .
Statistical Analysis
Incidence rates of ARI during the four-month periods in 1998 and 1999 were calculated and comparisons were made between vaccinated and unvaccinated workers, which were further stratified by occurrence of ARI in 1998. Hours of sickness absence were compared in the two groups of employees, vaccinated vs. unvaccinated. Bi-variate analyses comparing the differences between the two groups included chi-square tests for categorical variables and Student's t-tests for continuous variables.
In the multiple linear regression analysis, the dependent variable is the difference between the numbers of ARI clinic visits in the study periods of 1998 and 1999 for each individual. The independent variables were vaccination status, occurrence of ARI in 1998, age, gender, BMI (body mass index), evidence of diabetes mellitus, hypertension, hyperlipidemia, abnormal liver function and health behavior, including smoking, drinking and exercise habits.
Results
Of the 2,384 employees (mean age: 41.1 yr; range: 18 to 64 yr), 925 (39%) received the influenza vaccination between October and November 1998. The base-line characteristics of the subjects are summarized in Table  1 . The vaccinated employees were older than the unvaccinated employees (43.3 ± 8.0 vs. 39.5 ± 8.6, p=0.0001), with a significantly higher proportion of female employees (79.2% vs. 63.0%, p=0.001) and production line workers (68.8% vs. 60.9%, p=0.001). The number of current smokers was significantly higher in the unvaccinated group (14.3% vs. 8.8%, p=0.003).
The incidence rate of ARI (acute respiratory illness) among vaccinated and unvaccinated workers during January-April of 1998 and 1999 is summarized in Table  2 , and further stratified by the occurrence of ARI and clinic visits in 1998. The incidence rate of ARI in 1999 showed a 37.9% (26.4% in 1998 vs. 16 .4% in 1999) reduction compared with that of 1998. This reduction was significantly higher in the vaccinated workers (57.3%) than in the un-vaccinated workers (14.1%). Among the workers who had ARI in 1998, the incidence rate of ARI in 1999 was significantly lower in vaccinated workers than in unvaccinated workers (24.2% vs. 35.1%, p<0.003). Among the workers who did not have ARI in 1998, however, the incidence rate of ARI in 1999 did not show a significant difference in either vaccinated or unvaccinated workers (12.5% vs. 10.7%, p=0.24), as in Table 2 .
Total sickness absence due to all causes of illness in the 4-month period was reported to be 10,009 h in 1998 with an average of 3.6 h/person, and 7,554 h in 1999 Table 3 . The reduction of individual changes of frequencies of ARI visits was significantly associated with the influenza vaccination (0.20, 95% C.I. 0.28-0.12) after controlling for other determinants. Workers with occurrence of ARI in 1998 and with histories of diabetes were also found to be significant determinants in changes of frequencies of ARI visits. In addition, a one-year increase in age resulted in a 1% reduction in the ARI incidence (95% C.I. 0.6-1.4%).
Discussion
We found that a working population with a vaccination rate of around 40% showed an approximate 38% reduction of ARI clinic visits, with the vaccinated experiencing a significantly higher magnitude of reduction than the un-vaccinated group. The effectiveness in the reduction of the number of employees with ARI clinic visits was similar to the figures produced by the study conducted by Nicole KL et al. 2) , but it does not necessarily follow that such a big reduction can altogether be attributed to the vaccination program. Therefore we must examine carefully whether such a causal association can be tenable.
First, our study was conducted in a convenient company clinic, in which all employees were allowed to see their doctor during part of their working time. Even if a worker visited an outside clinic first when symptoms developed, he/she usually went to the company clinic for follow-up, so that there was a high utilization rate among all employees for health related problems like ARI and the data from the company medical department covering clinic visits of ARI was relatively comprehensive. Second, workers who visited the company clinic due to ARI more than once was only counted as once during the four-month period. Our estimation should be a more conservative one, as people might visit the clinic more than once or develop ARI-like symptoms due to a virus other than the influenza virus. Moreover, as we had the health examination results and a lifestyle survey for each employee, we applied a multivariate analysis to the individual effect of different determinants in the reduction of ARI visits. Table 3 shows that after controlling for age, gender, calendar year, diabetes mellitus, previous ARI attacks in 1998, hypertension, abnormal liver function, smoking, exercise and alcohol drinking habit, there was an independent significant effect due to the vaccination. Therefore, we tentatively concluded that the influenza vaccination is effective in the prevention of ARI visits for these employees. The results corroborated recent studies that also showed a half reduction of the incidence of febrile illness is due to an influenza vaccination among young, healthy adults 2, 16, 17) . In this study, younger workers had significantly more ARI clinic visits than older workers. The rates of Influenza and ARI attacks are usually the highest among children and teenagers 1) . As young workers tend to have children or teenagers living with them, they were more likely to have the disease transmitted from their children. Hurwitz et al. performed a single-blinded, randomized, controlled trial and found that when children received the influenza vaccine, their unvaccinated household contacts showed a 42% reduction in febrile illnesses 18) . Two other studies by Neuzil et al. and Izurieta et al. also supported the preventive effects of influenza vaccination for children and their family members 19, 20) . Therefore, we suggest that workers living with young children might also benefit from the influenza vaccination program.
The total reduction of sick leave in our study was 24.6% (2,455 h) in the period January to April. Based on the data, each vaccine recipient had an average of 0.63 h sickness absence less than non-recipients. For lack of detailed data on potential confounders, we still cannot attribute the reduction of sick leave totally to the vaccination program, but such a rough estimate of a reduction in sickness was equivalent to the productivity of 10 man-months in a large company of 2,500 employees. From the company's point of view, the productivity saving could be translated into the expense of 1,600 flu shots and cover 64% of employees. Based on this estimation, it seemed reasonable for an employer to pay at least half of the cost of the influenza vaccine for their employees.
Diabetes is a major determinant for immunity impairment, which was revealed in our multiple regression analysis, as shown in Table 3 . We noted that workers with diabetes had a 30 % higher incidence of ARI in the subsequent year. It implied that workers with such a disease might also be positively benefited by receiving the vaccination in the future to prevent ARI.
We concluded that the influenza vaccination is an effective workplace health promotion program, both for preventing influenza-like illnesses and probably reducing sickness absence. Besides, this study identified the following sub-populations that might be particularly benefited by the influenza vaccination: people who had ARI in the previous year, younger workers living with their children, and workers with diabetes. The application of influenza vaccination to working population should be considered for these specific subpopulations, especially under the recent threat of new emerging infectious diseases such as SARS and avian flu that may be confused with influenza in differential diagnosis.
